VERSARTIS INC's ticker is VSAR and the CUSIP is 92529L102. A total of 49 filers reported holding VERSARTIS INC in Q3 2018. The put-call ratio across all filers is 0.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $0 | -100.0% | 64 | -99.1% | 0.00% | – |
| Q2 2018 | $14,000 | +16.7% | 7,030 | -5.3% | 0.00% | – |
| Q1 2018 | $12,000 | – | 7,422 | +6968.6% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 105 | -97.9% | 0.00% | – |
| Q3 2017 | $12,000 | +1100.0% | 4,989 | +14573.5% | 0.00% | – |
| Q2 2017 | $1,000 | -95.0% | 34 | -96.3% | 0.00% | – |
| Q1 2017 | $20,000 | -60.0% | 925 | -72.1% | 0.00% | – |
| Q4 2016 | $50,000 | +233.3% | 3,318 | +176.5% | 0.00% | – |
| Q3 2016 | $15,000 | +15.4% | 1,200 | 0.0% | 0.00% | – |
| Q2 2016 | $13,000 | +30.0% | 1,200 | 0.0% | 0.00% | – |
| Q1 2016 | $10,000 | -37.5% | 1,200 | -3.7% | 0.00% | – |
| Q4 2015 | $16,000 | -38.5% | 1,246 | -44.5% | 0.00% | – |
| Q3 2015 | $26,000 | -38.1% | 2,247 | -19.3% | 0.00% | – |
| Q2 2015 | $42,000 | +90.9% | 2,784 | +132.0% | 0.00% | – |
| Q1 2015 | $22,000 | -18.5% | 1,200 | 0.0% | 0.00% | – |
| Q4 2014 | $27,000 | +17.4% | 1,200 | 0.0% | 0.00% | – |
| Q3 2014 | $23,000 | – | 1,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,296,471 | $51,556,000 | 25.09% |
| Aisling Capital LLC | 1,994,568 | $44,778,000 | 6.79% |
| Opaleye Management Inc. | 235,000 | $5,276,000 | 2.67% |
| Perceptive Advisors | 931,171 | $19,740,000 | 1.66% |
| HealthCor Management, L.P. | 875,000 | $19,644,000 | 1.10% |
| Cormorant Asset Management, LP | 200,000 | $4,490,000 | 0.69% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 644,150 | $14,461,000 | 0.63% |
| RA Capital Management | 231,267 | $5,192,000 | 0.56% |
| Baker Brothers Advisors | 2,281,744 | $51,225,000 | 0.52% |
| PFM Health Sciences, LP | 869,463 | $19,519,000 | 0.46% |